CSIMarket
 
Generation Bio Co   (NASDAQ: GBIO)
Other Ticker:  
 
 

Generation Bio Co Growth Comparisons

Select each growth Category to receive further Information



GBIO Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 252 % 9.75 % 7.3 % 3.85 %
Q / Q Revenue Growth (Q3 MRQ) 84.65 % 3.93 % 2.76 % 0.31 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 514.08 % 2.77 % 5.66 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 41.05 % 2.56 % 1.77 % 1.08 %
Revenue 5 Year Average Growth - 8.81 % 8.02 % 7.75 %


GBIO's Growth Comparisons in III. Quarter 2024




Impressive surge in Generation Bio Co 's Revenue in the third quarter 2024 by 252% from the same quarter a year ago, to 8 millions, appears to be a slow-down from Generation Bio Co 's growth trends, but competes favorably to the 9.75% growth in the Major Pharmaceutical Preparations industry, and 7.3% growth in the Healthcare sector. Above the average sales gains in the Healthcare and in the Major Pharmaceutical Preparations industry, helped to elevate overall market growth to 3.85%.

Top-line grew by 84.65% from the second quarter. Average yearly sales growth for Generation Bio Co is %, while S & P 500's average annual sales increase is 7.75% over the five years, including only Businesses with the third quarter 2024 Results.

GBIO Growth Rates by Company's Segments

Segment Name
Y / Y
Seq.
Total
252 %
84.65 %


Growth Rates of GBIO's Income in the third quarter 2024


GBIO Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - 90.42 % 80.05 % 4.22 %
Seq. Operating Income Change (Q3 MRQ) - 42.18 % 33.32 % -2.5 %
Y / Y Operating Income Growth (Q3 TTM) - -32.14 % -5.83 % 9.02 %
Seq. Operating Income Growth (Q3 TTM) - 29.44 % 19.93 % 1.36 %
Operating Income 5 Year Avg. Change - 3.05 % 6.12 % 9.16 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - 161.72 % 285.84 % -1.75 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - 59.34 % 119.47 % -8.86 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - -1.76 % 26.31 % 8.51 %
Seq. Income from Cont. Ops. Change (Q3 TTM) - 42.09 % 56.61 % -0.08 %
Income from Cont. Ops. 5 Year Avg. Change - -3.69 % -9.76 % 7.34 %

GBIO Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - -39.13 % 8.01 % -6.44 %
Q / Q Net Income Growth (Q3 MRQ) - 59.12 % 133.05 % -6.89 %
Y / Y Net Income Change (Q3 TTM) - -41.18 % -10.96 % 4.96 %
Seq. Net Income Change (Q3 TTM) - -26.14 % 2.56 % -1.41 %
Net Income 5 Year Avg. Growth - 4.4 % -3.41 % 7.48 %

GBIO's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - 180.79 % 285.84 % -1.75 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - 56.64 % 119.47 % -8.86 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) - - - -6.57 %
EPS from Cont. Ops. 5 Year Avg. Growth - -16.72 % -9.76 % 7.34 %



GBIO EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - -34.7 % 8.01 % -6.44 %
Q / Q EPS Net Growth (Q3 MRQ) - 56.43 % 133.05 % -6.89 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 44.84 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) - - - -6.16 %
EPS Net 5 Year Avg. Change - 4.4 % -3.41 % 7.48 %



Generation Bio Co reported bottom-line of $ -0.23 in the third quarter, compare to $ -0.43 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -34.7%, while Healthcare sector increased by 8.01%, and overall market declined by -6.44%.

The bottom-line grew by 84.65% from the second quarter. Average yearly income per share growth for Generation Bio Co is %, while S & P 500's average annual income per share increase is 7.48% over the five years, including only Businesses with the third quarter 2024 earnings reports.

GBIO Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - 38.16 % 37.8 % -41.98 %
Seq. Free Cash Flow Change (Q3 MRQ) - 201.6 % 107.49 % -35.8 %
Y / Y Free Cash Flow Change (Q3 TTM) - 1 % 4.24 % 3.46 %
Seq. Free Cash Flow Change (Q3 TTM) - 8.1 % 8.11 % -10.66 %
Free Cash Flow 5 Year Avg. Change - 11.97 % 7 % 11.99 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - -79.59 % -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) - - - -
Seq. Net Cash Flow Change (Q3 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - 1.42 % 11.22 % -33.53 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -85.08 % 1.99 % 1.51 % 2.82 %
Seq. Capital Expenditures Change (Q3 MRQ) 550 % 9.65 % 5.72 % 3.24 %
Y / Y Capital Expenditures Change (Q3 TTM) 88.71 % 5.59 % 3.04 % 69.35 %
Seq. Capital Expenditures Change (Q3 TTM) -7.29 % 1.69 % 2.03 % -0.5 %
Capital Expenditures 5 Year Avg. Change - 13.67 % 9.35 % 8.99 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com